BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25262254)

  • 1. Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
    Arnold SV; McGuire DK; Spertus JA; Li Y; Yue P; Ben-Yehuda O; Belardinelli L; Jones PG; Olmsted A; Chaitman BR; Kosiborod M
    Am Heart J; 2014 Oct; 168(4):457-465.e2. PubMed ID: 25262254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
    Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Katz A; Jones PG; Olmsted A; Belardinelli L; Chaitman BR
    J Am Coll Cardiol; 2013 May; 61(20):2038-45. PubMed ID: 23500237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
    Arnold SV; Kosiborod M; Li Y; Jones PG; Yue P; Belardinelli L; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):844-50. PubMed ID: 25249560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
    Arnold SV; McGuire DK; Spertus JA; Tang F; Yue P; Inzucchi SE; Belardinelli L; Chaitman BR; Kosiborod M
    Am Heart J; 2015 Oct; 170(4):753-759.e2. PubMed ID: 26386799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with ranolazine in a veteran population with chronic stable angina.
    Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
    Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
    Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
    Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
    Kohn CG; Parker MW; Limone BL; Coleman CI
    Am J Cardiol; 2014 Apr; 113(8):1306-11. PubMed ID: 24560062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
    Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ranolazine in patients with chronic stable angina.
    Kloner RA; Hines ME; Geunes-Boyer S
    Postgrad Med; 2013 Nov; 125(6):43-52. PubMed ID: 24200760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
    Keating GM
    Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.
    Timmis AD; Chaitman BR; Crager M
    Eur Heart J; 2006 Jan; 27(1):42-8. PubMed ID: 16176940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine for the treatment of refractory angina in a veterans population.
    Greene RS; Rangel RM; Edwards KL; Chastain LM; Brouse SD; Alvarez CA; Collins LJ; Brilakis ES; Banerjee S
    Cardiovasc Revasc Med; 2012; 13(2):141.e1-5. PubMed ID: 21856249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
    Arnold SV; Kosiborod M; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Spertus JA
    JAMA Intern Med; 2014 Aug; 174(8):1403-5. PubMed ID: 24887304
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
    Koren MJ; Crager MR; Sweeney M
    J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
    Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
    Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ranolazine in patients with stable angina pectoris.
    Khera S; Kolte D; Aronow WS
    Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    Fanaroff AC; James SK; Weisz G; Prather K; Anstrom KJ; Mark DB; Ben-Yehuda O; Alexander KP; Stone GW; Ohman EM
    J Am Coll Cardiol; 2017 May; 69(18):2304-2313. PubMed ID: 28473136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.